![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/485 | |
A61K 9/00 | |||
A61K 47/10 | |||
A61K 47/12 | |||
A61K 47/18 | |||
A61P 25/36 |
(11) | Number of the document | 3082816 |
(13) | Kind of document | T |
(96) | European patent application number | 14825055.8 |
Date of filing the European patent application | 2014-12-19 | |
(97) | Date of publication of the European application | 2016-10-26 |
(45) | Date of publication and mention of the grant of the patent | 2019-03-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/071371 |
Date | 2014-12-19 |
(87) | Number | WO 2015/095644 |
Date | 2015-06-25 |
(30) | Number | Date | Country code |
201361918802 P | 2013-12-20 | US |
(72) |
DEHART, Michael, Paul, US
WYSE, Joseph, US
|
(73) |
Indivior UK Limited,
103-105 Bath Road, Slough Berkshire SL1 3UH,
GB
|
(54) | INTRANASAL NALOXONE COMPOSITIONS AND METHODS OF MAKING AND USING SAME |
INTRANASAL NALOXONE COMPOSITIONS AND METHODS OF MAKING AND USING SAME |